2,3-bis(4-hydroxyphenyl)-propionitrile and Hormone-Dependent Neoplasms

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Hormone-Dependent Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasni, MS; Iravani, M; Jondal, M; Nilsson, S; Okret, S; Rhönnstad, P; Yakimchuk, K	1
Adami, HO; Andersson, SO; Andrén, O; Brown, M; Calza, S; Chinnaiyan, AM; Demichelis, F; Fall, K; Golub, TR; Hoshida, Y; Johansson, JE; Johnson, LA; Kantoff, PW; Lupien, M; Mertz, KD; Mucci, LA; Pawitan, Y; Perner, S; Rhodes, D; Rubin, MA; Sboner, A; Setlur, SR; Stampfer, MJ; Tang, J; Tomlins, S; Varenhorst, E	1

Other Studies

2 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Hormone-Dependent Neoplasms

Article	Year
Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo. Leukemia, 2011, Volume: 25, Issue:7 Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Burkitt Lymphoma; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Estradiol; Estrogen Receptor beta; Female; Humans; Liver Neoplasms, Experimental; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nitriles; Ovariectomy; Propionates; Species Specificity; Xenograft Model Antitumor Assays	2011
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. Journal of the National Cancer Institute, 2008, Jun-04, Volume: 100, Issue:11 Topics: Antineoplastic Agents, Hormonal; Area Under Curve; Blotting, Western; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; DNA, Complementary; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Health Surveys; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Oncogene Proteins, Fusion; Phenols; Physicians; Polymerase Chain Reaction; Propionates; Prostatic Neoplasms; Pyrazoles; Serine Endopeptidases; Signal Transduction; Sweden; Transfection	2008

Article

Year

Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.

Leukemia, 2011, Volume: 25, Issue:7

Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Burkitt Lymphoma; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Estradiol; Estrogen Receptor beta; Female; Humans; Liver Neoplasms, Experimental; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nitriles; Ovariectomy; Propionates; Species Specificity; Xenograft Model Antitumor Assays

2011

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.

Journal of the National Cancer Institute, 2008, Jun-04, Volume: 100, Issue:11

Topics: Antineoplastic Agents, Hormonal; Area Under Curve; Blotting, Western; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; DNA, Complementary; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Health Surveys; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Oncogene Proteins, Fusion; Phenols; Physicians; Polymerase Chain Reaction; Propionates; Prostatic Neoplasms; Pyrazoles; Serine Endopeptidases; Signal Transduction; Sweden; Transfection

2008